These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30926593)

  • 21. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?
    Arepally GM; Ortel TL
    Annu Rev Med; 2015; 66():241-53. PubMed ID: 25587651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies.
    Kim S; Namba J; Goodman AM; Nguyen T; Saunders IM
    J Oncol Pharm Pract; 2020 Mar; 26(2):351-360. PubMed ID: 31142232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.
    Man-Son-Hing M; Laupacis A
    Arch Intern Med; 2002 Mar; 162(5):541-50. PubMed ID: 11871922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke prevention in atrial fibrillation.
    Freedman B; Potpara TS; Lip GY
    Lancet; 2016 Aug; 388(10046):806-17. PubMed ID: 27560276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
    Lip GY
    J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant prevention in patients with atrial fibrillation: alternatives to vitamin K antagonists.
    Kozlowski D; Budrejko S; Raczak G; Rysz J; Banach M
    Curr Pharm Des; 2013; 19(21):3816-26. PubMed ID: 23286429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Edoxaban in venous thromboembolism and stroke prevention: an appraisal.
    Proietti M; Lip GY
    Vasc Health Risk Manag; 2016; 12():45-51. PubMed ID: 27013883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
    Korin J
    Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.
    Guo Y; Kotalczyk A; Imberti JF; Wang Y; Lip GY;
    Int J Stroke; 2022 Jul; 17(6):661-668. PubMed ID: 34551637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation.
    Fanaroff AC; Ohman EM
    Annu Rev Med; 2019 Jan; 70():61-75. PubMed ID: 30477393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation in the elderly.
    Henderson MC; White RH
    Curr Opin Pulm Med; 2001 Sep; 7(5):365-70. PubMed ID: 11584191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
    Blanco-Molina A
    Rev Clin Esp; 2012 Jan; 212 Suppl 1():3-7. PubMed ID: 23117646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Proietti M; Romanazzi I; Romiti GF; Farcomeni A; Lip GYH
    Stroke; 2018 Jan; 49(1):98-106. PubMed ID: 29167388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin--indications, risks and drug interactions.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.
    Forslund T; Komen JJ; Andersen M; Wettermark B; von Euler M; Mantel-Teeuwisse AK; Braunschweig F; Hjemdahl P
    Stroke; 2018 Sep; 49(9):2122-2128. PubMed ID: 30354995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes.
    Amin A; Marrs JC
    Clin Appl Thromb Hemost; 2016 Oct; 22(7):605-16. PubMed ID: 26316518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.